Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Shifting the cancer paradigm: must we kill to cure?

Literature DB >> 7707104

Shifting the cancer paradigm: must we kill to cure?

H Schipper, C R Goh, T L Wang.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 1995 PMID： 7707104 DOI： 10.1200/JCO.1995.13.4.801

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Current directions in chemotherapy for colorectal cancer.

Authors: Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal: J Gastroenterol Date: 2006-09 Impact factor: 7.527

2. From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer.

Authors: Sarah S Knox
Journal: Cancer Cell Int Date: 2010-04-26 Impact factor: 5.722

3. Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor.

Authors: Z An; X Wang; N Willmott; S K Chander; S Tickle; A J Docherty; A Mountain; A T Millican; R Morphy; J R Porter; R O Epemolu; T Kubota; A R Moossa; R M Hoffman
Journal: Clin Exp Metastasis Date: 1997-03 Impact factor: 5.150

4. Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma.

Authors: Irene Y Cheung; Yi Feng; Andrew Vickers; William Gerald; Nai-Kong V Cheung
Journal: J Mol Diagn Date: 2007-04 Impact factor: 5.568

Review 5. Murine models to evaluate novel and conventional therapeutic strategies for cancer.

Authors: James E Talmadge; Rakesh K Singh; Isaiah J Fidler; Avraham Raz
Journal: Am J Pathol Date: 2007-03 Impact factor: 4.307

6. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

Authors: M Müller; S Strand; H Hug; E M Heinemann; H Walczak; W J Hofmann; W Stremmel; P H Krammer; P R Galle
Journal: J Clin Invest Date: 1997-02-01 Impact factor: 14.808

Shifting the cancer paradigm: must we kill to cure?

Review 1. Current directions in chemotherapy for colorectal cancer.

2. From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer.

3. Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor.

4. Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma.

Review 5. Murine models to evaluate novel and conventional therapeutic strategies for cancer.

6. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

7. Chinese medicine and biomodulation in cancer patients--Part one.

8. Antineoplastic activity of idazoxan hydrochloride.

9. Implications of systemic dysfunction for the etiology of malignancy.

10. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs.